Darren has >10 years' experience in market access and digital health consultancy; his main role at P4A is identifying and developing innovative solutions for the market access and launch readiness challenges our customers face. Darren has a deep understanding of healthcare markets across Europe and amassed extensive experience with multi-stakeholder collaborations driving positive, sustainable, and innovative improvements to healthcare.
Prior to P4A, he worked at S3 Connected Health and Dolon, allowing him to develop expertise in market access and commercial strategy along with digital solution design for pharma and medtech. Darren has a BSc in physiology, MSc in biotechnology and business management from The University of Warwick and Prof Dip in Business Finance from Smurfit Business School. In his spare time, he enjoys playing and coaching basketball and hurling.
A pragmatic and interactive demonstration of the essential steps required to successfully prepare an orphan oncology drug for a future EU joint clinical assessment.
This workshop offers a hands-on, practical approach to navigating the new EU joint Health Technology Assessment (EUjHTA) framework, with a focus on orphan oncology drugs. Attendees will gain a clear understanding of the fundamental principles behind the EUjHTA, including its objectives, structure, and importance in the drug assessment landscape. The session will also delve into the timelines and requirements crucial for successful EUjHTA preparation. Through interactive demonstrations and expert insights, participants will learn the necessary steps to effectively plan and execute a comprehensive strategy to meet EUjHTA standards, ensuring a smoother pathway for future joint clinical assessment.
Senior Representative, RDI